In the livers of patients with NAFLD, the suppression of autophagy has been linked to increased accumulation of fat droplets, as determined by analyzing the expression of the autophagosome markers LC3-I/LC3-II and cargo receptor p62 [44,45]. Here, SQSTM1 is linked to metabolic dysfunction-associated steatotic liver disease.